Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs
Discover how AC1MMYR2, a novel drug targeting miR-21 biogenesis, reverses cancer's epithelial-mesenchymal transition and suppresses tumor growth.